Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
Study Details
Study Description
Brief Summary
The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric hematology-oncology patients.
Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Despite significant advances in anti-emetic treatment, chemotherapyinduced nausea and vomiting (CINV) is considered a major side-effect that significantly reduces the quality of life of children diagnosed with cancer. Guided imagery is one of the methods of distraction that allows the individual to go to an environment or scene that will make the individual comfortable, peaceful, happy, and focused.In this study, the participants will be randomized in a single blind manner (participant) to either intervention or control groups.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Guided imagery group Participants will receive guided imagery intervention. |
Other: guided imagery
The experimental group will listen to "Guided Imagery CD" prepared by the Turkish Psychological Association for relaxation 10 minute before the chemotherapy infusion. The remained part of CD, containing relaxing music and wave sound, will be played for 30 minutes after the chemotherapy infusion starts. When the chemotherapy infusion starts, the patients will be given imagery suggestions by a researcher, together with listening CD throughout first 30 minutes of chemotherapy infusion. Participants will be encouraged to think of various images: the patient will be asked to imagine that the treatment is over, that he/she is much healthier, that he/she heals very fast, that he/she returns to his/her old life in a short time, that he/she imagines himself/herself doing whatever he/she wants to do first after recovery, and that he/she imagines an object, person, event, situation, food or anything else that will make him/her feel good.
|
No Intervention: Control Participants will receive routine care. |
Outcome Measures
Primary Outcome Measures
- Nausea and vomiting [change from baseline 60 minutes of chemotherapy infusion]
Nausea and Vomiting Thermometer Scale in Children with Cancer is a 5-likert type scale. An increase in the score indicates an increase in the degree of nausea and vomiting experienced by children with cancer.
Secondary Outcome Measures
- Heart rate [change from baseline 60 minutes of chemotherapy infusion]
Maintaining or normalizing heart rate within normal range (60 to 110 bpm)
- Systolic and diastolic blood pressure [change from baseline 60 minutes of chemotherapy infusion]
Maintaining or normalizing systolic and blood pressure within normal range (systolic: 90-120 mmHg; diastolic 60-80 mmHg)
- Respiratory rate [change from baseline 60 minutes of chemotherapy infusion]
Maintaining or normalizing respiratory rate within normal range (18-30 breath per minute)
- Body temperature [change from baseline 60 minutes of chemotherapy infusion]
Maintaining or normalizing body temperature within normal range (36-37 C° in tympanic measurement)
- Oxygen saturation [change from baseline 60 minutes of chemotherapy infusion]
Maintaining or normalizing oxygen saturation within normal range (between 95%-100% by pulse oximetry)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
7 to 18 years old,
-
who will receive intravenous chemotherapy,
-
no cognitive or neurological disease that would prevent communication,
-
receiving a chemotherapy protocol with a high or moderate emetogenic effect according to the MASCC/ESMO Antiemetic Guideline Classification,
-
no verbal, visual and auditory communication disabilities (ability to speak Turkish, no mental deficiency),
-
children whose parents and themselves volunteered to participate in the study
Exclusion Criteria:
-
Children receiving radiotherapy,
-
having a history of seizures,
-
taking ginger powder or vitamins to reduce nausea,
-
children who did not want to participate in the study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hacettepe University İhsan Doğramacı Hospital | Ankara | Turkey | 06100 |
Sponsors and Collaborators
- Baskent University
- Hacettepe University
Investigators
- Principal Investigator: Ayşe Ay, RN, PhD, Baskent University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- KA23/180